Skip to main content
ADCT logo
ADCT
(NYSE)
ADC Therapeutics SA
$3.78-- (--)
Loading... - Market loading

ADC Therapeutics SA (ADCT) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

ADC Therapeutics SA Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
ADC Therapeutics SA income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue81.3670.8469.56209.9133.920.002.341.141.80
Cost of Revenue5.805.952.533.301.39141.820.00118.0985.53
Gross Profit67.75-44.75-60.10206.6132.52-141.822.34-116.95-83.73
Operating Expenses
Research & Development104.01109.63127.13186.46158.00142.03107.54118.3185.53
Selling, General & Administrative79.9385.91105.89143.49136.2477.2314.208.607.81
Operating Expenses182.0685.91105.89329.95293.8877.45121.74127.0893.47
Operating Income-108.38-130.65-165.99-123.34-261.35-219.26-119.40-125.94-91.67
Other Income/Expense
Interest Income8.8112.2710.542.570.070.832.252.861.03
Interest Expense51.63-50.21-46.3336.7318.344.930.160.000.00
Other Income/Expense-34.4012.546.40-33.5628.12-26.703.503.071.86
Income
Income Before Tax-141.61-156.14-195.42-156.90-251.51-245.96-115.90-122.87-89.81
Income Tax Expense-0.160.1739.110.23-21.480.330.580.220.05
Net Income-142.62-157.85-240.05-157.13-230.03-246.29-116.48-123.10-89.86
Net Income - Continuous Operations-142.62-157.85-240.05-157.13-230.03-246.29-116.48-123.10-89.86
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.000.00
EBITDA-119.62-127.38-162.72-107.70-230.54-218.23-114.10-122.36-91.33
EBIT-121.50-130.65-165.99-123.34-233.17-219.050.000.000.00
Depreciation & Amortization1.881.331.192.392.630.821.650.510.34
Earnings Per Share
Basic EPS-1.00-2.00-3.00-2.00-3.00-4.00-2.00-2.00-2.00
Diluted EPS-1.00-2.00-3.00-2.00-3.00-4.00-2.00-2.00-2.00
Basic Shares Outstanding127.0797.1681.7178.1576.6865.4166.8753.8358.85
Diluted Shares Outstanding127.0797.1681.7178.1576.6865.4166.8753.8358.85

Frequently Asked Questions About ADC Therapeutics SA Financial Statements

What is an income statement?

An income statement shows a company's revenues, expenses, and net income over a specific period. It reveals profitability by starting with revenue and subtracting costs to arrive at net income — the "bottom line" that shows how much the company earned.

What is ADCT's revenue trend?

Review ADC Therapeutics SA's quarterly and annual revenue figures in the income statement table above to identify growth trends, seasonal patterns, and year-over-year changes.

What is gross margin?

Gross margin is revenue minus cost of goods sold, expressed as a percentage. It shows how efficiently a company produces its goods or services. Higher gross margins indicate stronger pricing power and lower production costs.

What is operating income?

Operating income (EBIT) is revenue minus operating expenses, excluding interest and taxes. It measures a company's core business profitability before financing costs and tax effects, making it useful for comparing companies with different capital structures.

What is earnings per share (EPS)?

EPS divides net income by outstanding shares, showing the profit attributable to each share. Diluted EPS includes potential shares from stock options and convertible securities, providing a more conservative measure of per-share earnings.